Cargando…

Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma

AIM: To investigate the role of biomarkers in predicting postoperative liver dysfunction in patients with hepatocellular carcinoma (HCC). METHODS: A total of 200 patients operated from July 2009 to June 2010 at Zhongshan Hospital, Fudan University for pathologically confirmed HCC were retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yinghao, Shi, Guoming, Huang, Cheng, Zhu, Xiaodong, Chen, Si, Sun, Huichuan, Zhou, Jian, Fan, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621018/ https://www.ncbi.nlm.nih.gov/pubmed/26501145 http://dx.doi.org/10.1371/journal.pone.0140932

Ejemplares similares

Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma
Publicado: (2015)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study
por: Qi, Xingshun, et al.
Publicado: (2016)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
por: Zoheiry, Mona M, et al.
Publicado: (2015)

Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease
por: Parkes, Julie, et al.
Publicado: (2012)

Serum Autofluorescence, a Potential Serum Marker for the Diagnosis of Liver Fibrosis in Rats
por: Zhan, Yu-Tao, et al.
Publicado: (2012)

Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
por: Xu, Minghao, et al.
Publicado: (2022)

Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Kumagai, Erina, et al.
Publicado: (2016)

Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity
por: Zhang, Yuxin, et al.
Publicado: (2021)

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study
por: Qi, Xingshun, et al.
Publicado: (2015)

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease
por: Rath, Timo, et al.
Publicado: (2013)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Transient Elastography as the First-Line Assessment of Liver Fibrosis and Its Correlation with Serum Markers
por: Uzlova, Nikola, et al.
Publicado: (2023)

Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis
por: Mei, Ling, et al.
Publicado: (2022)

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
por: Chin, Jun L., et al.
Publicado: (2016)

Transient Elastography with Serum Hepatitis B Surface Antigen Enhances Liver Fibrosis Detection
por: Dai, Tianyi, et al.
Publicado: (2016)

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics
por: Chrostek, Lech, et al.
Publicado: (2019)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2020)

Preoperative Phenacetin Metabolism Test in the Prediction of Postoperative Liver Dysfunction of Patients with Hepatocellular Carcinoma
por: Pan, Xiaohua, et al.
Publicado: (2017)

Correction to: Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis
por: Mei, Ling, et al.
Publicado: (2023)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis
por: Hohenester, Simon, et al.
Publicado: (2020)

Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis
por: Sangiovanni, Angelo, et al.
Publicado: (2021)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Schistosomal liver fibrosis and hepatocellular carcinoma – case series of patients submitted to liver transplantation
por: Filgueira, Norma Arteiro, et al.
Publicado: (2018)

Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
por: Shirata, Chikara, et al.
Publicado: (2018)

Association of nonalcoholic fatty liver disease and liver fibrosis detected by transient elastography with serum retinol in American adults
por: Niu, Xiaoxian, et al.
Publicado: (2023)

Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease
por: Zeng, Da-Wu, et al.
Publicado: (2013)

Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India
por: Cepeda, Javier A., et al.
Publicado: (2016)

Mac-2 Binding Protein Glycosylation Isomer: Emerging Non-Invasive Serum Marker for Liver Fibrosis
por: Cho, Sun Young, et al.
Publicado: (2018)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
por: Song, Do Seon, et al.
Publicado: (2019)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: A cross-sectional observational study
por: Kularaj, Seetaram Singh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3lmbm8e35pkqv35i622fjf9al